Welcome to BioMarket Group!

Electronic Data Capture and Management: Assessing Opportunities to Streamline the Clinical Trial Process

Additional Information

Published Date Jun 11, 2004
Special Offer No
Pages 40
PDF Fact Sheet View Fact Sheet for the report Electronic Data Capture and Management: Assessing Opportunities to Streamline the Clinical Trial Process in PDF format.
Published on Date No
Format No
Publisher Datamonitor
Product Line No
Full Title Electronic Data Capture and Management: Assessing Opportunities to Streamline the Clinical Trial Process

Availability: In stock

$3,800.00

Quick Overview

Electronic data capture (eDC) technology will improve the quality of data collected at clinical trial sites by reducing errors inherent in the current data collection system. Pharmaceutical companies looking to adopt eDC technology should choose an eDC vendor that is able to demonstrate global scalability, as well as offer an integrated end-to-end clinical data management solution.
Request free sample pages from Electronic Data Capture and Management: Assessing Opportunities to Streamline the Clinical Trial Process

Introduction

Electronic data capture (eDC) technology will improve the quality of data collected at clinical trial sites by reducing errors inherent in the current data collection system. Pharmaceutical companies looking to adopt eDC technology should choose an eDC vendor that is able to demonstrate global scalability, as well as offer an integrated end-to-end clinical data management solution.

Scope

  • Analyzes the evolving eDC market, including general strategies for assessing eDC vendors
  • Defines characteristics of eDC vendors that are important to long-term stability in the market
  • Explores the challenges companies will face when switching from a paper-based to an electronic data capture-based clinical trial process
  • Looks at current industry leaders operating within the eDC market, including their best practices and opportunities for improvement

Highlights

Electronic data capture can provide better data and a more efficient clinical trial process, including improvements in data quality, a streamlined review process and ultimately faster time to market. By reducing the length of the drug development process, sponsors can increase the return on their investment and better distribute their resources.

Market growth is likely to take place slowly and unevenly as companies move out of the pilot phase. One important barrier to market stabilization and wide-scale adoption of electronic data capture technology is the difficulty that vendors have developing solutions well-suited for the wide range of companies operating within the industry.

As the regulatory environment moves towards standardization of the clinical trial process and as clinical trials grow in scope and size, the eDC market will likely narrow to include less than half-a-dozen financially stable vendors that offer end-to-end solutions.

Reasons to Purchase

  • Understand the current and prospective electronic data capture vendor market and where the key opportunities for your company lie
  • Recognize how implementing a robust and integrated electronic data capture process is critical to preparing for future FDA eSubmission initiatives
  • Understand the limitations and opportunities offered by each vendor and hasten eDC adoption by choosing the best vendor for your data capture needs
Request free sample pages from Electronic Data Capture and Management: Assessing Opportunities to Streamline the Clinical Trial Process

Other selected research from the 'IT & eHealth' category:


European Healthcare Provider IT Spending (Interactive Model)
The model contains IT spending forecasts for healthcare provider organizations, from 2006 to 2011. It covers Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Turkey and the UK. Learn More


eHealth Solutions for Pharma: Strategies for salesforces, marketing, patient compliance and clinical trials
A new report that provides an overview of the changing pharma market place, providing solutions on effective three way communication between pharmaceutical companies, patients and physicians. Learn More

Other selected research from the 'Management' category:


Pharma Market Authorization Strategies: A guide to launching drugs quickly and efficiently in Europe
This report is a comprehensive source of market analysis of the most valuable therapy area within the global pharmaceutical market; Valued at an estimated $73.7bn in 2002, the global market for cardiovascular drugs grew by a moderate 2.5% over 2001 levels Learn More


Benchmarking Best Practice at Patent Expiry in Europe - Maximizing Return on Investment of Late-Stage Lifecycle Management
Successfully managing the lifecycle of molecules within marketed portfolios is an essential capability for the pharma industry. With R&D productivity stalling, and profit margins increasingly eroded by cost containment initiatives, maximizing the return on investment of in-line brands, by extending the time on the market without generic competition, is a key objective for pharmaceutical companies. Learn More